Agilent Technologies, Inc. (NYSE:A) CEO Michael R. Mcmullen Sells 128,726 Shares

Agilent Technologies, Inc. (NYSE:AGet Rating) CEO Michael R. Mcmullen sold 128,726 shares of the business’s stock in a transaction dated Tuesday, November 22nd. The shares were sold at an average price of $155.73, for a total value of $20,046,499.98. Following the completion of the sale, the chief executive officer now directly owns 260,691 shares of the company’s stock, valued at $40,597,409.43. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Agilent Technologies Trading Down 1.0 %

Shares of A stock opened at $155.35 on Friday. The firm has a market capitalization of $45.99 billion, a PE ratio of 37.25, a price-to-earnings-growth ratio of 2.78 and a beta of 1.06. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.41 and a current ratio of 2.03. Agilent Technologies, Inc. has a 1 year low of $112.52 and a 1 year high of $162.62. The stock has a fifty day moving average of $133.99 and a two-hundred day moving average of $128.48.

Agilent Technologies (NYSE:AGet Rating) last posted its quarterly earnings data on Monday, November 21st. The medical research company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.14. The business had revenue of $1.85 billion during the quarter, compared to the consensus estimate of $1.76 billion. Agilent Technologies had a net margin of 18.31% and a return on equity of 30.31%. The company’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.21 earnings per share. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.64 EPS for the current year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 25th. Investors of record on Tuesday, January 3rd will be issued a dividend of $0.225 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Friday, December 30th. This represents a $0.90 annualized dividend and a yield of 0.58%. Agilent Technologies’s payout ratio is presently 20.14%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on A shares. started coverage on Agilent Technologies in a report on Wednesday, October 12th. They issued a “strong-buy” rating for the company. Wells Fargo & Company raised their price target on shares of Agilent Technologies from $135.00 to $150.00 in a research report on Tuesday. Cowen boosted their price objective on shares of Agilent Technologies from $160.00 to $168.00 in a research report on Tuesday. Credit Suisse Group initiated coverage on shares of Agilent Technologies in a report on Wednesday, August 24th. They issued an “outperform” rating and a $165.00 target price on the stock. Finally, Jefferies Financial Group upped their target price on Agilent Technologies from $158.00 to $168.00 in a report on Tuesday. Four investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. According to, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $157.00.

Institutional Investors Weigh In On Agilent Technologies

A number of institutional investors have recently added to or reduced their stakes in the company. Bromfield Sneider Wealth Advisors bought a new position in shares of Agilent Technologies during the 2nd quarter valued at about $31,000. EverSource Wealth Advisors LLC grew its position in Agilent Technologies by 34.8% in the third quarter. EverSource Wealth Advisors LLC now owns 298 shares of the medical research company’s stock worth $37,000 after buying an additional 77 shares during the last quarter. Edge Capital Group LLC increased its holdings in shares of Agilent Technologies by 53.0% in the third quarter. Edge Capital Group LLC now owns 303 shares of the medical research company’s stock valued at $37,000 after buying an additional 105 shares in the last quarter. Guardian Wealth Advisors LLC acquired a new stake in shares of Agilent Technologies during the 3rd quarter valued at $42,000. Finally, J.W. Cole Advisors Inc. boosted its stake in shares of Agilent Technologies by 7,201.6% during the 1st quarter. J.W. Cole Advisors Inc. now owns 124,493 shares of the medical research company’s stock worth $45,000 after acquiring an additional 122,788 shares in the last quarter.

Agilent Technologies Company Profile

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

See Also

Insider Buying and Selling by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with's FREE daily email newsletter.